MPM BioImpact’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-70,000
| Closed | -$639K | – | 41 |
|
|
2023
Q4 | $639K | Sell |
70,000
-277,332
| -80% | -$2.53M | 0.15% | 32 |
|
|
2023
Q3 | $3.6M | Buy |
347,332
+65,000
| +23% | +$674K | 0.96% | 29 |
|
|
2023
Q2 | $4.04M | Buy |
282,332
+69,717
| +33% | +$998K | 0.81% | 30 |
|
|
2023
Q1 | $1.52M | Buy |
212,615
+16,673
| +9% | +$119K | 0.39% | 27 |
|
|
2022
Q4 | $2.2M | Buy |
195,942
+2,616
| +1% | +$29.4K | 0.57% | 27 |
|
|
2022
Q3 | $2.14M | Hold |
193,326
| – | – | 0.51% | 30 |
|
|
2022
Q2 | $1.63M | Hold |
193,326
| – | – | 0.45% | 33 |
|
|
2022
Q1 | $2.63M | Buy |
+193,326
| New | +$2.63M | 0.71% | 32 |
|